3Coiling J. An update on the AHCPR guideline implementation. Nurse Practice Forum, 1994,5 : 134-137.
4McGuire EJ, Bennett CJ, Konnak JA, et al. Experience with pubovaginal slings for urinary incontinence at the university of Michigan. J Urol, 1987,138:525-529.
5Buckner S ,Milicic I ,Daza A ,et al. ABT-866 ,a novel alpha(1A) -adrenoceptor agonist with antagonist properties at the alpha ( 1B )- andalpha ( 1 D) -adrenoceptor subtypes. Eur J Pharmacol, 2002,449 : 159-165.
6Brune ME, O' Neill AB, Gauvin DM, et al. Comparison of alpha 1-adrenoceptor agonists in canine urethral pressure profilometry and abdominal leak point pressure models. J Urol,2001,166 : 1555-1559.
7Nito H. Clinical effect of midodfine hydrochlofide on the patients with urinary incontinence. Hinyokika Kiyo, 1994,40:91-94.
8Weil EH,Eerdmans PH, Dijkman GA, et al. Randomized double-blind placebo-controlled muhicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase Ⅱ study. Int Urogynecol J Pelvic FloorDvsfunct, 1998,9 : 145-150.
9Zeenat Eva Khan, Javed Rizvi. Non-surgical management of urinary stress incontinence [ J ]. Review in Gynaecological Practice, 2005,5: 237 - 242.
10Dan HM ,McGrother CW ,Mathews RJ,et al. Lercester-shire MRC Incontinence Study Group. The association of diet and other life style factors with overactive bladder and stress incontinence: a longitudinal study in women[J]. BJU Int,2003 ,92: 69 -77.
